Differential repetitive DNA methylation in multiple myeloma molecular subgroups

Carcinogenesis

Volumn 30, Issue 8, 2009, Pages 1330-1335

  Bollati, Valentina ^a   Fabris, Sonia ^a   Pegoraro, Valeria ^a   Ronchetti, Domenica ^a   Mosca, Laura ^a   Deliliers, Giorgio Lambertenghi ^a   Motta, Valeria ^a   Bertazzi, Pier Alberto ^a   Baccarelli, Andrea ^a   Neri, Antonino ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA METHYLTRANSFERASE; LONG INTERSPERSED NUCLEAR ELEMENT 1; ONCOPROTEIN; PROTEIN ALU; SATELLITE ALPHA; UNCLASSIFIED DRUG; DNA; DNA (CYTOSINE 5 ) METHYLTRANSFERASE 1; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA (CYTOSINE-5-)-METHYLTRANSFERASE 1; SATELLITE DNA;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CHROMOSOMAL INSTABILITY; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; ADULT; AGED; ALU SEQUENCE; CHROMOSOME ABERRATION; CLASSIFICATION; CPG ISLAND; GENETICS; LONG INTERSPERSED REPEAT; MIDDLE AGED; NUCLEOTIDE REPEAT; PATHOLOGY; PLASMA CELL LEUKEMIA; TUMOR CELL CULTURE;

ADULT; AGED; AGED, 80 AND OVER; ALU ELEMENTS; CHROMOSOME ABERRATIONS; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; DNA, NEOPLASM; DNA, SATELLITE; FEMALE; HUMANS; LEUKEMIA, PLASMA CELL; LONG INTERSPERSED NUCLEOTIDE ELEMENTS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; REPETITIVE SEQUENCES, NUCLEIC ACID; TUMOR CELLS, CULTURED;

EID: 69449085661     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgp149     Document Type: Article

References (50)

1. Kuehl, W. M. et al. (2002) Multiple myeloma: Evolving genetic events and host interactions. Nat. Rev. Cancer, 2, 175-187.
2. Lombardi, L. et al. (2007) Molecular characterization of human multiple myeloma cell lines by integrative genomics: Insights into the biology of the disease. Genes Chromosomes Cancer, 46, 226-238.
3. Hallek, M. et al. (1998) Multiple myeloma: Increasing evidence for a multistep transformation process. Blood, 91, 3-21.
4. Kastrinakis, N. G. et al. (2000) Molecular aspects of multiple myeloma. Ann. Oncol., 11, 1217-1228.
5. Galm, O. et al. (2004) DNA methylation changes in multiple myeloma. Leukemia, 18, 1687-1692.
6. Feinberg, A. P. (2007) Phenotypic plasticity and the epigenetics of human disease. Nature, 447, 433-440.
7. Jones, P. A. (1986) DNA methylation and cancer. Cancer Res., 46 461-466.
8. Rodriguez, J. et al. (2006) Chromosomal instability correlates with genomewide DNA demethylation in human primary colorectal cancers. Cancer Res., 66, 8462-9468.
9. Yang, A. S. et al. (2004) A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res., 32, e38.
10. Weisenberger, D. J. et al. (2004) Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol. Cancer Res., 2, 62-72.
11. Okano, M. et al. (1998) Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19, 219-220.
12. Okano, M. et al. (1999) DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247-257.
13. Das, P. M. et al. (2004) DNA methylation and cancer. J. Clin. Oncol., 22, 4632-4642.
14. Boultwood, J. et al. (2007) Gene silencing by DNA methylation in haematological malignancies. Br. J. Haematol., 138, 3-11.
15. Fabris, S. et al. (2005) Characterization of oncogene dysregulation in multiple myeloma by combined FISH and DNA microarray analyses. Genes Chromosomes Cancer, 42, 117-127.
16. Mattioli, M. et al. (2005) Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma. Oncogene, 24, 2461-2473.
17. Durie, B. G. et al. (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer, 36, 842-854.
18. Agnelli, L. et al. (2007) Upregulation of translational machinery and distinct genetic subgroups characterise hyperdiploidy in multiple myeloma. Br. J. Haematol., 136, 565-573.
19. Bollati, V. et al. (2007) Changes in DNA methylation patterns in subjects exposed to low-dose benzene. Cancer Res., 67, 876-880.
20. Agnelli, L. et al. (2005) Molecular classification of multiple myeloma: A distinct transcriptional profile characterizes patients expressing CCND1 and negative for 14q32 translocations. J. Clin. Oncol., 23, 7296-7306.
21. Fabris, S. et al. (2007) Transcriptional features of multiple myeloma patients with chromosome 1q gain. Leukemia, 21, 1113-1116.
22. Chen, R. Z. et al. (1998) DNA hypomethylation leads to elevated mutation rates. Nature, 395, 89-93.
23. Schulz, W. A. et al. (2002) Genomewide DNA hypomethylation is associated with alterations on chromosome 8 in prostate carcinoma. Genes Chromosomes Cancer, 35, 58-65.
24. Rizwana, R. et al. (1999) CpG methylation reduces genomic instability. J. Cell Sci., 112, 4513-4519(Pt 24).
25. Xu, G. L. et al. (1999) Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature, 402, 187-191.
26. Eden, A. et al. (2003) Chromosomal instability and tumors promoted by DNA hypomethylation. Science, 300, 455.
27. Lengauer, C. et al. (1997) DNA methylation and genetic instability in colorectal cancer cells. Proc. Natl Acad. Sci. USA, 94, 2545-2550.
28. Wong, N. et al. (2001) Hypomethylation of chromosome 1 heterochromatin DNA correlates with q-arm copy gain in human hepatocellular carcinoma. Am. J. Pathol., 159, 465-471.
29. Fonseca, R. et al. (1999) Cytogenetic abnormalities in multiple myeloma. Hematol. Oncol. Clin. North Am., 13, 1169-1180.
30. Seidl, S. et al. (2003) New insights into the pathophysiology of multiple myeloma. Lancet Oncol., 4, 557-564.
31. Ng, M. H. et al. (1997) Frequent hypermethylation of p16 and p15 genes in multiple myeloma. Blood, 89, 2500-2506.
32. Gonzalez, M. et al. (2000) De novo methylation of tumor suppressor gene p16/INK4a is a frequent finding in multiple myeloma patients at diagnosis. Leukemia, 14, 183-187.
33. Kramer, A. et al. (2002) Centrosome replication, genomic instability and cancer. Leukemia, 16, 767-775.
34. Mateos, M. V. et al. (2002) Methylation is an inactivating mechanism of the p16 gene in multiple myeloma associated with high plasma cell proliferation and short survival. Br. J. Haematol., 118, 1034-1040.
35. Guillerm, G. et al. (2001) p16(INK4a) and p15(INK4b) gene methylations in plasma cells from monoclonal gammopathy of undetermined significance. Blood, 98, 244-246.
36. Guillerm, G. et al. (2003) Different prognostic values of p15(INK4b) and p16(INK4a) gene methylations in multiple myeloma. Haematologica, 88, 476-478.
37. Gonzalez-Paz, N. et al. (2007) Tumor suppressor p16 methylation in multiple myeloma: Biological and clinical implications. Blood, 109, 1228-1232.
38. Chim, C. S. et al. (2004) Methylation profiling in multiple myeloma. Leuk. Res., 28, 379-385.
39. Roman-Gomez, J. et al. (2008) Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia. Leuk. Res., 32 487-490.
40. Hoffmann, M. J. et al. (2005) Causes and consequences of DNA hypomethylation in human cancer. Biochem. Cell Biol., 83, 296-321.
41. Sawyer, J. R. et al. (1998) Jumping translocations of chromosome 1q in multiple myeloma: Evidence for a mechanism involving decondensation of pericentromeric heterochromatin. Blood, 91 1732-1741.
42. Sawyer, J. R. et al. (1998) Identification of new nonrandom translocations in multiple myeloma with multicolor spectral karyotyping. Blood, 92, 4269-4278.
43. Fassas, A. B. et al. (2002) Both hypodiploidy and deletion of chromosome 13 independently confer poor prognosis in multiple myeloma. Br. J. Haematol., 118, 1041-1047.
44. Fonseca, R. et al. (2003) The recurrent IgH translocations are highly associated with nonhyperdiploid variant multiple myeloma. Blood, 102, 2562-2567.
45. Keats, J. J. et al. (2003) In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Blood, 101, 1520-1529.
46. Chang, H. et al. (2004) The t(4;14) is associated with poor prognosis in myeloma patients undergoing autologous stem cell transplant. Br. J. Haematol., 125, 64-68.
47. Smadja, N. V. et al. (2001) Hypodiploidy is a major prognostic factor in multiple myeloma. Blood, 98, 2229-2238.
48. Chen, Z. X. et al. (2005) Maintenance and regulation of DNA methylation patterns in mammals. Biochem. Cell Biol., 83, 438-448.
49. Li, E. et al. (1992) Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell, 69 915-926.
50. Li, S. et al. (2003) DNA hypomethylation and imbalanced expression of DNA methyltransferases (DNMT1, 3A, and 3B) in human uterine leiomyoma. Gynecol. Oncol., 90, 123-130.